Nothing
#' @name lrstat-package
#' @aliases lrstat-package
#'
#' @title Power and Sample Size Calculation for Non-Proportional Hazards
#' and Beyond
#'
#' @description Performs power and sample size calculation for
#' non-proportional hazards model using the Fleming-Harrington family
#' of weighted log-rank tests.
#'
#' @details For proportional hazards, the power is determined by the
#' total number of events and the constant hazard ratio along with
#' information rates and spending functions. For
#' non-proportional hazards, the hazard ratio varies over time and
#' the calendar time plays a key role in determining the mean and
#' variance of the log-rank test score statistic. It requires an
#' iterative algorithm to find the calendar time at which the
#' targeted number of events will be reached for each interim
#' analysis. The lrstat package uses the analytic method
#' in Lu (2021) to find the mean and variance of the weighted
#' log-rank test score statistic at each interim analysis. In
#' addition, the package approximates the variance and covariance
#' matrix of the sequentially calculated log-rank test statistics
#' under the alternative hypothesis with that under the null hypothesis
#' to take advantage of the independent increments structure in
#' Tsiatis (1982) applicable for the Fleming-Harrington family
#' of weighted log-rank tests.
#'
#' The most useful functions in the package are \code{lrstat},
#' \code{lrpower}, \code{lrsamplesize}, and \code{lrsim}, which calculate
#' the mean and variance of log-rank test score statistic at a sequence
#' of given calendar times, the power of the log-rank test, the sample
#' size in terms of accrual duration and follow-up duration, and the
#' log-rank test simulation, respectively. The \code{accrual} function
#' calculates the number of patients accrued at given calendar times. The
#' \code{caltime} function finds the calendar times to reach the targeted
#' number of events. The \code{exitprob} function calculates the stagewise
#' exit probabilities for specified boundaries with a varying mean
#' parameter over time based on an adaptation of the recursive
#' integration algorithm described in Chapter 19 of Jennison and
#' Turnbull (2000).
#'
#' The development of the lrstat package is heavily influenced by
#' the rpact package. We find their function arguments to be
#' self-explanatory. We have used the same names whenever appropriate
#' so that users familiar with the rpact package can learn the
#' lrstat package quickly. However, there are notable differences:
#' \itemize{
#' \item lrstat uses direct approximation, while rpact uses the Schoenfeld
#' method for log-rank test power and sample size calculation.
#' \item lrstat uses \code{accrualDuration} to explicitly set the end of
#' accrual period, while rpact incorporates the end of accrual period
#' in \code{accrualTime}.
#' \item lrstat considers the trial a failure at the last stage if
#' the log-rank test cannot reject the null hypothesis up to this
#' stage and cannot stop for futility at an earlier stage.
#' \item the \code{lrsim} function uses the variance of the log-rank
#' test score statistic as the information.
#' }
#'
#' In addition to the log-rank test power and sample size calculations,
#' the lrstat package can also be used for the following tasks:
#' \itemize{
#' \item design generic group sequential trials.
#' \item design generic group sequential equivalence trials.
#' \item design adaptive group sequential trials for changes in sample
#' size, error spending function, number and spacing or future looks.
#' \item calculate the terminating and repeated confidence intervals for
#' standard and adaptive group sequential trials.
#' \item calculate the conditional power for non-proportional hazards
#' with or without design changes.
#' \item perform multiplicity adjustment based on graphical approaches
#' using weighted Bonferroni tests, Bonferroni mixture of weighted
#' Simes test, and Bonferroni mixture of Dunnett test as well as
#' group sequential trials with multiple hypotheses.
#' \item perform multiplicity adjustment using stepwise gatekeeping
#' procedures for two sequences of hypotheses and the standard or
#' modified mixture gatekeeping procedures in the general case.
#' \item design parallel-group trials with the primary endpoint
#' analyzed using mixed-model for repeated measures (MMRM).
#' \item design crossover trials to estimate direct treatment
#' effects while accounting for carryover effects.
#' \item design one-way repeated measures ANOVA trials.
#' \item design two-way ANOVA trials.
#' \item design Simon's 2-stage trials.
#' \item design modified toxicity probability-2 (mTPI-2) trials.
#' \item design Bayesian optimal interval (BOIN) trials.
#' \item design group sequential trials for negative binomial
#' endpoints with censoring.
#' \item design trials using Wilcoxon, Fisher's exact, and McNemar's test.
#' \item calculate Clopper-Pearson confidence interval for single
#' proportions.
#' \item calculate Brookmeyer-Crowley confidence interval for quantiles
#' of censored survival data.
#' \item calculate Miettinen & Nurminen confidence interval for stratified
#' risk difference, risk ratio, odds ratio, rate difference, and
#' rate ratio.
#' \item perform power and sample size calculation for logistic regression.
#' \item perform power and sample size calculation for Cohen's kappa.
#' \item calculate Hedges' g effect size.
#' \item generate random numbers from truncated piecewise exponential
#' distribution.
#' \item perform power and sample size calculations for negative binomial
#' data.
#' }
#'
#' @author Kaifeng Lu, \email{kaifenglu@@gmail.com}
#'
#' @references
#' Anastasios A. Tsiatis. Repeated significance testing for a general class
#' of statistics used in censored survival analysis. J Am Stat Assoc.
#' 1982;77:855-861.
#'
#' Christopher Jennison, Bruce W. Turnbull. Group Sequential Methods with
#' Applications to Clinical Trials. Chapman & Hall/CRC: Boca Raton, 2000,
#' ISBN:0849303168
#'
#' Kaifeng Lu. Sample size calculation for logrank test and prediction of
#' number of events over time. Pharm Stat. 2021;20:229-244.
#'
#'
#' @seealso rpact, gsDesign
#'
#' @examples
#' lrpower(kMax = 2, informationRates = c(0.8, 1),
#' criticalValues = c(2.250, 2.025), accrualIntensity = 20,
#' piecewiseSurvivalTime = c(0, 6),
#' lambda1 = c(0.0533, 0.0309), lambda2 = c(0.0533, 0.0533),
#' gamma1 = 0.00427, gamma2 = 0.00427,
#' accrualDuration = 22, followupTime = 18)
#'
#' @useDynLib lrstat, .registration = TRUE
#' @importFrom Rcpp evalCpp
#' @importFrom mvtnorm pmvnorm
#' @importFrom stats dgamma dlogis dnorm formula integrate model.frame
#' model.matrix optimize pbeta pchisq pf plogis pnorm pt qbeta qchisq
#' qf qlogis qnorm qt terms uniroot var
#' @importFrom lpSolve lp
#' @importFrom shiny shinyAppDir
#'
NULL
Any scripts or data that you put into this service are public.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.